摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

c-hexylethyl isocyanate | 76649-96-2

中文名称
——
中文别名
——
英文名称
c-hexylethyl isocyanate
英文别名
(2-Isocyanatoethyl)cyclohexane;2-isocyanatoethylcyclohexane
c-hexylethyl isocyanate化学式
CAS
76649-96-2
化学式
C9H15NO
mdl
——
分子量
153.224
InChiKey
FRZASDFCNJQWML-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    29.4
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-氟脲嘧啶c-hexylethyl isocyanate吡啶4-二甲氨基吡啶 作用下, 生成 N-(2-cyclohexylethyl)-5-fluoro-2,4-dioxopyrimidine-1-carboxamide
    参考文献:
    名称:
    通过卡莫氟结构引导的命中到先导优化发现抗病毒 SARS-CoV-2 主要蛋白酶抑制剂
    摘要:
    严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 主要蛋白酶 (M pro ) 已成为开发针对 COVID-19 感染的抗 SARS-CoV-2 药物的目标,因为 M pro处理必需的病毒多蛋白并发挥关键作用在 SARS-CoV-2 复制中的作用。在这项研究中,我们报告了源自卡莫氟的新型 SARS-CoV-2 M pro抑制剂的开发,卡莫氟是一种先前鉴定的化合物,作为 SARS-CoV-2 M pro的共价抑制剂显示出中等效力。为了采用结构引导的药物设计策略,首先通过对接模拟预测了卡莫氟在 M pro催化活性位点上的假定完整结合模式。基于预测的结合模式,对一系列旨在占据M pro底物结合区域的卡莫氟衍生物进行了构效关系分析。结果, 发现了一种基于吲哚的衍生物,推测与 S4 结合袋相互作用, 21b (IC 50 = 1.5 ± 0.1 μM)。通过结合对接模拟、自由能扰动计算和子口
    DOI:
    10.1016/j.ejmech.2023.115720
  • 作为产物:
    描述:
    2-(2-cyclohexylethyl)isoindoline-1,3-dione 在 甲烷一水合肼 作用下, 以 乙醇乙酸乙酯 为溶剂, 反应 3.0h, 生成 c-hexylethyl isocyanate
    参考文献:
    名称:
    N-Alkenyl and cycloalkyl carbamates as dual acting histamine H3 and H4 receptor ligands
    摘要:
    Previous studies have shown that several imidazole derivatives posses affinity to histamine H-3 and H-4 receptors. Continuing our study on structural requirements responsible for affinity and selectivity for H-3/H-4 receptor subtypes, two series of 3-(1H-imidazol-4-yl) propyl carbamates were prepared: a series of unsaturated alkyl derivatives (1-9) and a series possessing a cycloalkyl group different distances to the carbamate moiety (10-13). The compounds were tested for their affinities at the human histamine H3 receptor, stably expressed in CHO-K1 cells. Compounds 1, 2, 5-7, 10-13 were investigated for their affinities at the human histamine H-4 receptor co-expressed with G alpha(i2) and G beta(1)gamma(2) subunits in Sf9 cells. To expand the pharmacological profile, compounds were further tested for their H3 receptor antagonist activity on guinea pig ileum and in vivo after oral administration to mice. All tested compounds exhibited good affinity for the human histamine H-3 receptor with K-i values in the range from 14 to 194 nM. All compounds were active in vivo after peroral administration (p.o.) to Swiss mice, thus demonstrating their ability to cross the blood-brain barrier. The most potent H-3 receptor ligand of these series was compound 5, 3-(1H-imidazol-4-yl) propyl pent-4-enylcarbamate with the highest affinity (K-i = 14 nM). Additionally, compound 3 showed remarkable central nervous system (CNS) H3R activity, increasing the N-tau-methylhistamine levels in mice with an ED50 value of 0.55 mg/kg, p.o. evidencing therefore, a twofold increase of inverse agonist/antagonist potency compared to the reference inverse agonist/antagonist thioperamide. In this study, the imidazole propyloxy carbamate moiety was kept constant. The different lipophilic moieties connected to the carbamate functionality in the eastern part of the molecule had a range of influences on the human H-4 receptor affinity (154-1326 nM). (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2011.03.046
点击查看最新优质反应信息

文献信息

  • 5-Fluorouracil Derivatives. XXII. Synthesis and Antitumor Activities of 1-Carbamoyl-5-fluorouracils.
    作者:Shoichiro OZAKI、Xiangzheng KONG、Yutaka WATANABE、Tomonori HOSHIKO、Toshikazu KOGA、Tomio OGASAWARA、Tsuneharu TAKIZAWA、Hiroshi FUJISAWA、Masaaki IIGO、Akio HOSHI
    DOI:10.1248/cpb.45.1372
    日期:——
    Fifty-four 1-carbamoyl-5-fluorouracils were synthesized from 5-fluorouracil and isocyanate or amine. Antitumor activity was tested in the L-1210 tumor system, and 11 compounds gave better values of therapeutic ratio than HCFU (1-hyxylcarbamoyl-5-fluorouracil). 1-(4-Methoxycyclohexylcarbamoyl)-5-fluorouracil gave the best result.
    从5-氟尿嘧啶和异氰酸酯或胺合成了54个1-羧酰胺基-5-氟尿嘧啶。在L-1210瘤株体系中测试了其抗肿瘤活性,有11个化合物的治疗比值优于HCFU(1-羟基羰酰胺基-5-氟尿嘧啶)。其中1-(4-甲氧基环己基羰酰胺基)-5-氟尿嘧啶的效果最佳。
  • [EN] SYNTHESIS OF INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1<br/>[FR] SYNTHÈSE D'INHIBITEURS DE LA 11?-HYDROXYSTÉROÏDE DÉHYDROGÉNASE DE TYPE 1
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2010010150A1
    公开(公告)日:2010-01-28
    Disclosed are syntheses of 11β-HSD1 inhibitors and corresponding intermediates that are promising for the treatment of a variety of disease states including diabetes, metabolic syndrome, obesity, glucose intolerance, insulin resistance, hyperglycemia, hypertension, hypertension-related cardiovascular disorders, hyperlipidemia, deleterious gluco-corticoid effects on neuronal function (e.g. cognitive impairment, dementia, and/or depression), elevated intra-ocular pressure, various forms of bone disease (e.g., osteoporosis), tuberculosis, leprosy (Hansen's disease), psoriasis, and impaired wound healing (e.g., in patients that exhibit impaired glucose tolerance and/or type 2 diabetes).
    披露了合成11β-HSD1抑制剂及相应中间体的方法,这些方法对治疗包括糖尿病、代谢综合征、肥胖、葡萄糖耐量不良、胰岛素抵抗、高血糖、高血压、与高血压相关的心血管疾病、高脂血症、糖皮质激素对神经功能的有害影响(例如认知障碍、痴呆症和/或抑郁症)、眼内压升高、各种骨病(例如骨质疏松症)、结核病、麻风病(汉森病)、牛皮癣以及伤口愈合受损(例如在表现出糖耐量不良和/或2型糖尿病的患者中)等多种疾病状态具有前景。
  • Hypoglycaemic agents
    作者:D F Hayman、V Petrow、O Stephenson
    DOI:10.1111/j.2042-7158.1964.tb07510.x
    日期:2011.4.12
    Abstract

    Various 3-substituted derivatives of 1-(p-vinylbenzenesulphonyl)urea, 1-[p-(2-chloroethyl)benzenesulphonyl]urea and 1-[p-(2-bromoethyl)benzenesulphonyl]urea are described. Several of the compounds possess noteworthy hypoglycaemic activity on oral administration in rabbits. In contrast, several related 5-substituted derivatives of 2-[p-(2-chloroethyl)benzenesulphonamido]-1,3,4-thiadiazoles and -1,3,4-oxadiazoles were virtually inactive.

    标题:摘要 描述了1-(对乙烯基苯磺酰基)脲、1-[对-(2-氯乙基)苯磺酰基]脲和1-[对-(2-溴乙基)苯磺酰基]脲的各种3-取代衍生物。其中几种化合物在兔子口服后表现出显著的降糖活性。相比之下,几种相关的2-[对-(2-氯乙基)苯磺酰胺基]-1,3,4-噻二唑和-1,3,4-噁二唑的5-取代衍生物几乎没有活性。
  • Non-<i>C</i><sub>2</sub>-Symmetric Chiral-at-Ruthenium Catalyst for Highly Efficient Enantioselective Intramolecular C(sp<sup>3</sup>)–H Amidation
    作者:Zijun Zhou、Shuming Chen、Yubiao Hong、Erik Winterling、Yuqi Tan、Marcel Hemming、Klaus Harms、K. N. Houk、Eric Meggers
    DOI:10.1021/jacs.9b09301
    日期:2019.12.4
    A new class of chiral ruthenium catalysts is introduced in which ruthenium is cyclometalated by two 7-methyl-1,7-phenanthrolinium heterocycles, resulting in chelating pyridylidene remote N-heterocyclic carbene ligands (rNHCs). The overall chirality results from a stereogenic metal center featuring either a Λ or Δ absolute configuration. This work features the importance of the relative metal-centered
    介绍了一类新的手性钌催化剂,其中钌被两个 7-甲基-1,7-菲咯啉杂环环金属化,导致螯合吡啶亚远程 N-杂环卡宾配体 (rNHC)。整体手性来自具有 Λ 或 Δ 绝对构型的立体金属中心。这项工作的特点是相对以金属为中心的立体化学的重要性。只有非 C2 对称手性钌配合物对 1,4,2-二恶唑-5-酮的分子内 C(sp3)-H 酰胺化显示出前所未有的催化活性,可提供高达 99 的手性 γ-内酰胺: 1 er 和催化剂负载量低至 0.005 mol %(高达 11 200 TON),而 C2 对称非对映异构体有利于不希望的 Curtius 型重排。
  • Synthesis of aliphatic isocyanates via a two-phase Hofmann reaction
    作者:Anita O. Sy、Joseph W. Raksis
    DOI:10.1016/0040-4039(80)80008-6
    日期:1980.1
    A convenient method of preparing aliphatic isocyanates via a two-phase Hofmann reaction using a phase transfer catalyst is described.
    描述了一种使用相转移催化剂通过两相霍夫曼反应制备脂族异氰酸酯的简便方法。
查看更多

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰